{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:47:30Z","timestamp":1789386450961,"version":"build-2803163510"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,2,1]]},"DOI":"10.1093\/brain\/124.2.331","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:48:15Z","timestamp":1027709295000},"page":"331-340","source":"Crossref","is-referenced-by-count":90,"title":["Intravenous apomorphine therapy in Parkinson's disease: Clinical and pharmacokinetic observations"],"prefix":"10.1093","volume":"124","author":[{"given":"A. J.","family":"Manson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["Brain"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/124\/2\/331\/1124873\/1240331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T20:59:00Z","timestamp":1503435540000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/124.2.331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,1]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1093\/brain\/124.2.331","relation":{},"ISSN":["1460-2156"],"issn-type":[{"value":"1460-2156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,1]]}}}